Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Aortic endografts (EVAR/TEVAR) · Alabama | Aortic endografts (EVAR/TEVAR) · Florida | |
|---|---|---|
| Surgeons, 2024 | 2 | 10 |
| Medicare fee-for-service cases | 218 | 1,226 |
| Growth since 2019 (Medicare FFS) | −11%/yr | −4.3%/yr |
| Forecast cases (Medicare FFS) | 230 in 2030 | 1,210 in 2030 |
| Forecast growth | +1%/yr to 2030 | −0.2%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.5 | 0.6 |
| Medicare Advantage share | 64% | 60% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (+0 pts since 2019) |
| Cases per surgeon | 109 | 123 |
| Top 10 surgeons' share | 100% | 100% |
| Surgeons growing | 0 | 0 |
| New since the base year | 0 | 1 |
| Likely to stop billing it | 2 by 2026 | 6 by 2026 |
| Forecast miss, 1 year (procedure) | 10% | 10% |
| Company payments per surgeon | $35K | $27K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.